SCHEMBL433434

SCHEMBL433434

COC1(OC2(OC)CCCCC2)CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28469156 1.00
SCHEMBL1855220 0.97
SCHEMBL14777911 0.87
SCHEMBL6159241 0.87
SCHEMBL14779193 0.87
SCHEMBL1816711 0.87
SCHEMBL112037 0.87
SCHEMBL1816192 0.87
SCHEMBL731782 0.83
SCHEMBL11794407 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 264 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230049294-A1 STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES Atea Pharmaceuticals, Inc. (US) 2023-02-16 US claimed
WO-2021216722-A1 STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES Atea Pharmaceuticals, Inc. (US) 2021-10-28 WO claimed
CN-104530417-B A kind of multiple functionalized H types polyethyleneglycol derivative and preparation method thereof 厦门赛诺邦格生物科技股份有限公司 2017-09-08 CN claimed
CN-104530415-B A kind of different functionalization Y types polyethyleneglycol derivative, preparation method and its bio-related substance 厦门赛诺邦格生物科技股份有限公司 2017-09-01 CN claimed
CN-104530415-A Hetero-functionalized Y-type polyethylene glycol derivative, preparation method and biologically related substance thereof XIAMEN SINOPEG BIOTECH INC 2015-04-22 CN claimed
CN-104530417-A Multifunctional H-type polyethylene glycol derivative and preparation method thereof XIAMEN SINOPEG BIOTECH INC 2015-04-22 CN claimed
EP-1979362-B1 NOVEL SILANE COMPOUNDS AND USE THEREOF IN ORDER TO FUNCTIONALISE SOLID MEDIA AND IMMOBILISE BIOLOGICAL MOLECULES ON SAID MEDIA COMMISSARIAT ENERGIE ATOMIQUE (FR) 2010-12-15 EP claimed
EP-1885703-A4 PROCESSES FOR PRODUCTION OF PHENOLIC 4-BIPHENYLYLAZETIDIN-2-ONES MICROBIA INC (US) 2009-09-02 EP claimed
US-20090099355-A1 Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic Acids MICROBIA, INC. (US) 2009-04-16 US claimed
US-20090005269-A1 Novel Silane Compounds and Their Use in Functionalizing Solid Supports and Immobilizing Biological Molecules on These Supports CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2009-01-01 US claimed
EP-1893571-A2 PROCESS FOR PRODUCTION OF 4-BIPHENYLYAZETIDIN-2-ONES Microbia Inc. (US) 2008-03-05 EP claimed
EP-1885703-A2 PROCESSES FOR PRODUCTION OF PHENOLIC 4-BIPHENYLYLAZETIDIN-2-ONES Microbia, Inc. (US) 2008-02-13 EP claimed
WO-2007088186-A1 NOVEL SILANE COMPOUNDS AND USE THEREOF IN ORDER TO FUNCTIONALISE SOLID MEDIA AND IMMOBILISE BIOLOGICAL MOLECULES ON SAID MEDIA COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2007-08-09 WO claimed
WO-2006127893-A2 PROCESSES FOR PRODUCTION OF 4-(BIPHENYLYL)AZETIDIN-2-ONE PHOSPHONIC ACIDS MICROBIA, INC. (US) 2006-11-30 WO claimed
WO-2006122020-A2 PROCESS FOR PRODUCTION OF 4-BIPHENYLYAZETIDIN-2-ONES MICROBIA, INC. (US) 2006-11-16 WO claimed
WO-2006122216-A2 PROCESSES FOR PRODUCTION OF PHENOLIC 4-BIPHENYLYLAZETIDIN-2-ONES MICROBIA, INC. (US) 2006-11-16 WO claimed
EP-1105404-B1 PURIFICATION OF OLIGOMERS USING DUAL-END SELECTION BAYER AG (US) 2003-10-29 EP claimed
US-6472522-B1 Purification of oligomers using dual-end selection BAYER CORPORATION 2002-10-29 US claimed
EP-1105404-A1 PURIFICATION OF OLIGOMERS USING DUAL-END SELECTION Bayer Corporation (US) 2001-06-13 EP claimed
WO-2000012524-A1 PURIFICATION OF OLIGOMERS USING DUAL-END SELECTION BAYER CORPORATION (US) 2000-03-09 WO claimed